Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the twice-yearly injection into doubt.

‘God, It’s Terrifying’: How the Pentagon Got Hooked on AI War Machines
21:14

How a Die-Hard Libertarian Is Negotiating Lower Health-Care Costs
22:36

James Patterson’s Authorship Operation Welcomes Viola Davis and MrBeast
38:15